Topic Listing for Bristol-Myers Squibb Company

Abbott Laboratories Litigation Abilify
Abilify State Attorneys General Investigation Abn Amro Bank
Acceptance Accounting Auditors Corporate Accounts Approval Annual
Accounting Policies Accrual Accounting Significant Assumptions
Accrued Expenses Accumulated Other Comprehensive Income Loss
Accuracy Fair Value Estimates Acquired In-process Research Development
Acquisitions Acquisitions Divestitures
Acting Chief Financial Officer Activities
Additional Information Address Principal Executive Office
Administrative Agents Administrative Information Plan
Adnexus Therapeutics Adopted Pursuant 906 Sarbanes-oxley Act 2002
Advance Notice Procedures Adverse Event Reporting
Adversely Impacted Economic Factors Beyond Control Adversely Impacted Economic Factors Beyond Control Incur Additional
Advertising Costs Advertising Product Promotion
Agreement Terms Aircraft Time Sharing Agreement
Alliance Agreements Alliances Collaborations
Also Named Board Directors Amended Effective 2004
Amendment Bylaws Amendment Plan Termination
Amendments Amendments Articles Incorporation Bylaws Change
Analysis Changes Updated Guidance Andrew Bonfield
Andrew Bonfield Certify Annex Ii-a
Annex Ii-b Announces Eps Guidance 2006
Announces Eps Guidance 2007 Announces Indicative Dividend Increase 2008 Declares Quarterly
Annual Awards Annual Incentive Deferral Plan
Annual Incentives Annual Meeting Stockholders
Anthony Hooper Antitrust Litigation
Apotex Halt Sales Unauthorized Generic Appendix Statement Facts
Applicable Only Corporate Issuers Approval Awards
Approval Restated Certificate Incorporation Effecting Amendment Eliminate Certain Assignment
Assistance Questions Astrazeneca
Atripla Attend Annual Meeting
Attorneys Office New Jersey Audit Committee
Audit Committee Report Audit Non-audit Fees
Auditor Fees Availability Corporate Governance Documents
Available Annual Report Form 10-k 2007 Was Filed Avista Capital Partners
Award Deferrals Award Recipient
Awp Litigation Baltimore Downstate Delaware
Banca Intesa Spa London Branch Banca Monte Dei Paschi Siena Spa
Banco Bilbao Vizcaya Argentaria Banco Santander Central Hispano
Bank America Bank New York
Bank Tokyo-mitsubishi Ltd Branch Barclays Bank Plc
Bari Italy Investigation Base Salary
Based Knowledge Financial Statements Other Information Included Annual Basic Severance
Basis Consolidation Basis Presentation New Accounting Standards
Become Subject New Government Laws Regulations Such Health Been Material Changes Risk Factors Disclosed 2007 Form
Benchmarking Process Compensation Strategy Beneficial Ownership Reporting Compliance
Benefit Paid Benefits Programs Coverage
Between Undersigned Biopharmaceuticals
Bms Pharmaceuticals Netherlands Holdings Bnp Paribas
Bnp Paribas Ireland Board Directors
Board Directors Recommends Vote Against Proposal Following Reasons Board Independence
Board Meeting Procedures Board Responsibilities
Boards Role Strategic Planning Bonus Deferment
Borrower Borrower Financial Covenant
Boston Bristol-myers Squibb
Bristol-myers Squibb Achieves Strong Sales Earnings Performance Bristol-myers Squibb Acquire Adnexus Therapeutics
Bristol-myers Squibb Acquire Medarex Bristol-myers Squibb Advance Biologics Strategy Through Targeted Acquisition
Bristol-myers Squibb Announces Debt Tender Offer Bristol-myers Squibb Brian Henry 609-252-3337 Communications Pete Paradossi
Bristol-myers Squibb Completes Acquisition Medarex Inc Bristol-myers Squibb Forward-looking Statement
Bristol-myers Squibb Luxembourg International Sca Bristol-myers Squibb Names Vicki Sato Board Directors
Bristol-myers Squibb Registrant Bristol-myers Squibb Reports 2006 Financial Results
Bristol-myers Squibb Reports 2007 Financial Results Bristol-myers Squibb Reports Financial Results 2005 Reflecting Ongoing
Bristol-myers Squibb Securities Litigation Bristol-myers Squibb Updates 2009 Continuing Operations Financial Guidance
Bristol-myers Squibb Website Business Combinations
Business Development Update Business Environment
Business Financial Performance Business Segments
California 340b Litigation Calyon
Canada Capital Assets Depreciation
Capitalized Software Car
Cardiovascular Metabolics Cash Compensation
Cash Compensation Program Cash Discounts
Cash Equivalents Cash Flow Hedges
Cash Flows Cash Severance -as Disclosed Cda Approximately Senior Executives
Categorical Standards Independence Cause
Cautionary Factors Affect Future Results Centrally Funded Programs Expenses
Ceo Compensation Cercla Matters
Certain Relationships Related Transactions Certificate Authentication
Certificates Transfers Shares Certification Chairman Board Chief Executive Officer
Certification Chief Executive Officer Certification Chief Financial Officer
Certification Senior Vice President Chief Financial Officer Chairman Compensation
Chairman Compensation Robinson Change Control
Change Control Arrangements Change Registrants Independent Registered Public Accounting Firm
Change Vote After Return Proxy Card Voting Telephone Change-in-control Arrangements
Changes Foreign Currency Exchange Rates Interest Material Adverse Changes Internal Control Over Financial Reporting
Charitable Contribution Program Charitable Contribution Programs
Citibank Claim Benefits
Claims Review Procedures Clayworth Litigation
Closing Budget Gaps Through Channel Stuffing Improper Accounting Codes Conduct
Collaboration Agreement Commitment Rights Obligations Transferred
Commitment Shareholder Value Committee Directors Corporate Governance
Committee Matters Committees Board
Common Stock Ownership Directors Executive Officers Communication Presents Only Overview Complete Proxy Materials Available
Communications Board Directors Comparison 5-year Cumulative Total Return
Comparison Cumulative Total Return Comparison Five-year Cumulative Total Return
Compensation Benefits Compensation Ceo
Compensation Committee Interlocks Insider Participation Compensation Consultant
Compensation Decisions Compensation Directors
Compensation Interim Ceo Compensation Management Development Committee
Compensation Management Development Committee Report Compensation Management Development Committee Report Executive
Compensation New Cfo Compensation Program Design
Competition Components 2007 Compensation Program
Composition Composition Structure Board
Conditions Conditions Closing
Conference Call Information Confidentiality
Confidentiality Agreement Confirms 2007-2010 Non-gaap Eps Cagr Expects Minimum 030
Consent Independent Registered Public Accounting Firm Consideration
Consignment Consolidated Financial Statements
Consolidated Financial Statements Statement Schedule Consolidation Merger Sale Lease Conveyance
Consumer Fraud Consumer Fraud Action
Consumer Medicines Contacts
Contingencies Continuation Employee Benefits Puerto Rico Expatriate Executives Above
Contracts Checks Drafts Bank Accounts Etc Contractual Obligations
Contributions Contributions Holdings
Controls Procedures Convatec
Convatec Italy Investigation Convatec Segment
Corporate Citizenship Corporate Form
Corporate Governance Corporate Governance Board Matters
Corporate Governance Guidelines Corporate Name
Corporate Other Corporate Purpose
Cost Active Substance Chemical Bulk Cost Bulk
Cost Products Sold Costs Products Sold
Counts Votes Covenants
Creation Direct Financial Obligation Off-balance Sheet Arrangement Credit Ratings
Criteria Board Membership Critical Accounting Policies
Data Protection Plavix Expired Faces Competition European Markets Dated 2005 Agreement
Debt Owed Participating Employer Debt Securities
Decisions Partners Deductibility Compensation Over
Default Deferral Program
Deferred Compensation Program Deferred Taxes
Defined Benefit Pension Plans Definition
Definitions Delayed Recognition Actuarial Gains Losses
Deliberate Rebate Under-accrual Delivers Significant Strategic Initiatives
Departure Directors Certain Officers Election Appointment Compensatory Departure Directors Principal Officers Election Appointment
Depends Key Products Most Net Sales Cash Flows Derivative Financial Instruments
Design Designate Proxy
Determination Record Date Determining Individual Compensation Executives
Deutsche Bank London Branch Developments
Difference 2008 Payout Results Between 2007-2009 2008-2010 Awards Director Compensation
Director Compensation Program Director Independence
Director Qualifications Directors Executive Officers Registrant
Directors Whose Terms Expire 2006 Dissolution
Distributions Partners Dividends
Donald Hayden Executive Vice President Americas Double-double Mega-double Top Down Budgeting
Due 2014 Due 2019
Due 2039 Earnings Before Minority Interest Income Taxes
Earnings Continuing Operations Before Income Taxes Minority Interest Earnings Continuing Operations Before Minority Interest Income Taxes
Earnings Guidance Estimates Earnings Per Share
Economic Factors Effect Other Benefits
Eligibility Eligibility Participate
Eligibility Severance Payments Benefits Elliott Sigal Phd
Employee Assistance Program Eap Employee Stock Benefit Plans
Employee Stock Plans Employees
Employment Eligibility I-9 Documentation Employment Status
Enfamil Enforce Rights
Entitled Vote Entry Material Definitive Agreement
Environmental Proceedings Environmental Regulation
Equity Compensation Equity Compensation Plan Information Table
Equity Grant Policy Equity Investments
Equity Net Income Affiliates Erbitux
Erisa Litigation Estimated End-user Demand
Estimated Future Benefit Payments Estimated Hand Wholesaler Distribution Channel 2004
Estimated Hand Wholesaler Distribution Channel 2005 Estimates
European Union Evaluation Disclosure Controls Procedures
Events Default Exact Name Registrant Specified Charter
Excellent Performance Highlights Bristol-myers Squibb Excluding Estimated Impact Launch Generic Clopidogrel Bisulfate
Excluding Projected Specified Excluding Specified
Execution Copy Execution Strategy
Executive Car Program Executive Committee
Executive Compensation Executive Compensation Philosophy
Executive Compensation Policies Executive Officer Compensation
Executive Officers Registrant Executive Sessions
Executive Sessions Presiding Director Executive Summary
Exelixis Exemption
Exhibits Expansion Productivity Additional 2012
Experience Difficulties Delays Development Commercialization New Products Experience Difficulties Delays Manufacturing Sale Products
Explanatory Exploitation Modalities
Extension Benefits Rule Face
Faces Competition Other Pharmaceutical Manufacturers Including Lower-priced Generic Faces Increased Pricing Pressure Abroad Managed Care Organizations
Faces Intense Competition Other Pharmaceutical Manufacturers Including Lower-priced Failure Execute Business Strategy Adversely Impact Growth Profitability
Fair Price Provision Fair Value Hedges
False Misleading Disclosure Federal Income Tax Implications 2007 Plan
Federal Income Tax Implications Performance Plan Federal Investigation Pricing Sales Marketing Practices
Final Results Exchange Offer Financial Highlights
Financial Instruments Financial Outlook
Financial Performance Financial Planning
Financial Position Liquidity Capital Resources Financial Results
Financial Statement Exhibits Financial Statements Exhibits
Financing Activities Following Paragraphs Included Only Restricted Security
Following Press Release Attorney Following Table Provides Reconciliation General Administrative Gaap Non-gaap
Foreign Currency Translation Foreign Exchange Risk
Foreign Laws Regulations Negatively Affect Sales Profit Margins Foreign Operations
Foreign Regulations Negatively Affect Sales Profit Margins Form 10-k
Form Accession Letter Form Compliance Certificate
Form Notes Due 2014 Form Notes Due 2019
Form Notes Due 2039 Form Notice Exclusive Control
Form Resignation Letter Form Transfer Certificate
Former Name Address Changed Since Last Report Formula
Fortis Bank Forward Looking Statements
Forward-looking Statements Further Issues
Gain Sale Imclone Shares Gain Sale Product Lines Businesses
General General Commercial Litigation
General Employee Benefits General Release
General Release Restrictive Covenants Generic Competition
Generics Termination Fee Geographic Areas
Gilead Good Reason
Goodwill Goodwill Other Intangible Assets
Governing Law Government Regulation Price Constraints
Governor Bank Ireland Grant Effective Date
Grant License Grant Price
Gross Margin Marketing Selling Administrative Research Development Tax Gross Margin Research Development Marketing Selling Administrative Tax
Gross Margin Research Development Tax Rate Projections Gross Margin Research Development Tax Rate Projections Excluding
Gross Margin Tax Rate Projections Excluding Specified Gross Net Sales Adjustments
Gross-to-net Sales Adjustments Growth Excess Inventory
Guarantee Guidance
Half 2006 Half 2007
Headquarters Health Care Group
Health Care Plans Health Care Resources Litigation
Hedge Net Investment Highlight Bristol-myers Squibb
Holders Common Stock Holders Lists Reports Trustee
Hormone Replacement Therapy Hsbc Bank Usa National Association
Http Wwwspringhillsuitescom Bossd Identification Selection Nominees Board
Illegal Distribution Sale Parties Counterfeit Versions Products Negative Imclone
Immunology Impact New Strategy Compensation Program
Impact Projected Specified Impairment Long-lived Assets
Important Notice Regarding Internet Availability Proxy Materials 2008 Important Notice Regarding Internet Availability Proxy Materials 2009
Incentive Plan Income Tax
Income Taxes Increasingly Dependent Information Technology
Increasingly Dependent Information Technology Outsourcing Arrangements Incremental Targeted Investments Robust Pipeline
Indemnification Contribution Indemnification Officers Directors
Indemnitor Corporation Limited Liability Partnership Sign Below Indemnitor Individual Sign Below
Index Indicate Check Whether Registrant Accelerated Filer Defined Rule
Indicate Check Whether Registrant Large Accelerated Filer Non-accelerated Ineligibility Severance Payments Benefits
Information Information External Sources
Information Filing 2005 Form 10-q Information Technology
Intellectual Property Intellectual Property Product Exclusivity
Interest Rate Contracts Interest Rate Risk
Interest Rate Swaps Outstanding Internal Control Over Financial Reporting
International International Pharmaceuticals Nutritionals Other Health Care
Introduction Inventories
Inventories Net Inventory Valuation
Investigation Pricing Sales Marketing Practices Investigational Compounds Development
Investigational Oral Treatment Type Diabetes Investigations
Investigations Office Attorney Massachusetts Investing Activities
Investments Invitation Self-identify
Involuntary Termination Not Cause Involvement Senior Management
James Cornelius James Cornelius Chairman Board
Japan Jean-marc Huet
Jpmorgan Chase Bank Lamberto Andreotti
Lead Independent Director Leadership Development
Leases Led Double-digit Global Net Sales Growth Strong Earnings
Led Double-digit Global Sales Growth Legal Action
Legal Matters Adverse Outcomes Negatively Affect Business Legal Proceedings
Legal Proceedings Contingencies License Steering Committee
Licensed Patents Licensed Trademarks
Life Insurance Lilly
Limited Perquisites Line Products
Litigation Litigation Expense Net
Litigation Plavix Litigation-plavix
Long Term Care Plan Not Applicable Executives Puerto Long Term Performance Awards
Long-term Debt Long-term Incentive Plan Awards Last
Long-term Incentives Long-term Performance Award
Long-term Performance Award Program Design Long-term Performance Awards
Long-term Performance Awards Last Mact Compliance-puerto Rico Facilities Barceloneta Humacao
Making Numbers Managed Care Organizations
Managed Health Care Rebates Other Contract Discounts Management
Management Changes Managements Report Internal Control Over Financial Reporting
Mandatory Cost Formula Manipulation Corporate Reserves
Manufacturing Manufacturing Quality Assurance
Marked Positive Pipeline Developments Market Prices
Marketable Securities Marketing Distribution Customers
Marketing Selling Administrative Marketing Selling Administrative Expenses Continuing Operations
Mead Johnson Mead Johnson Facility-nsps Issue
Mead Johnson Nutrition Mead Johnson Nutrition Initial Public Offering
Mead Johnson Nutritionals Medarex
Medarex Inc Acquisition Medarex Shareholder Litigation
Medicaid Rebates Medical Imaging
Medical Plan Meeting Date Location
Meetings Meetings Board
Meetings Shareholders Member Compensation
Memorandum Mercers Role
Merck Metabolics Cardiovascular
Milestone Payments Minneapolis Firefighters Relief Association Jean Lai Litigations
Minority Interest Miscellaneous
Miscellaneous Provisions Mitigation
Mizuho Corporate Bank Usa More-
Morgan Stanley Bank Name Person Filing Proxy Statement Other Registrant
Natural Gas Contracts Net Cash Debt
Net Earnings Net Financial Assets
Net Sales Neuroscience
New Adnectin Product Class Profusion System New Brunswick Facility Environmental Personal Injury Lawsuits
New Drug Approved New Jersey
New Plan Benefits 2007 New Plan Benefits Performance
New Product Pipeline Developments New Product Pipeline Progress
New Product Pipeline Update New York
Njdep Air Permit-new Brunswick Facility Nominees Directors
Nominees Directors Term Expiring 2006 Non-compete Non Solicitation Agreement General Release
Non-gaap Financial Information Non-qualified Deferred Compensation
Non-qualified Deferred Compensation Plan Non-qualifying Foreign Exchange Contracts
Noncontrolling Interest Nordic Capital
Nordic Capital Fund Avista Partners Agree Acquire Convatec Nordic Capital Group Private Equity Funds Focusing Primarily
North Brunswick Board Education Remediation Claims North Brunswick Township Board Education
North Brunswick Township Board Education Claims Not Less 095 Gaap Basis Non-gaap
Notes Notes Definitive Form
Notes Due 2018 Notes Due 2036
Notes Due 2038 Nothing Plan Change Control Letter Agreement Offer Participating
Notice Serves Admission Ticket Meeting Admits Only Stockholder Notices
Nutritional Nutritionals
Nutritionals Related Healthcare Nutritionals Segment
Ods Regulatory Compliance Officers
Offices Offset Executives Puerto Rico Expatriates
Omnicare Qui Tam Litigation Oncology
Operating Activities Option Exercises Stock Vesting
Option Sar Grants Last Optional Redemption Notes
Oral Statements Orencia
Orencia Approval Dasatinib Submission Other Adjustments
Other Administrative Facts Other Awards
Other Benefits Other Compensation
Other Developments Other Elements 2007 Compensation
Other Elements 2008 Compensation Other Events
Other Expense Income Net Other Expense Net
Other Health Care Other Health Care Segment
Other Healthcare Other Healthcare Segment
Other Income Expense Other Income Expense Net
Other Intangible Assets Other Intellectual Property Litigation
Other Litigation Other Matters
Other Patent Infringement Litigation Other Patent Litigation
Other Perquisites Other Pharmaceuticals
Other Proceedings Other Securities Matters
Otn Distribution Business Equity Partners Llc Otsuka
Outlook Outlook 2005
Outplacement Overview 2007 Plan Awards
Page Parachute Tax Indemnity Provisions
Paragraph Certifications Received Parent Guarantor Financial Covenant
Park Avenue New York 10154 Park Located Orange Street Between 11th 12th Streets
Parking Part
Part Conditions Precedent Initial Utilisation Part Conditions Precedent Required Delivered Additional Guarantor
Part Ii-other Information Part Original Lenders
Part Original Obligors Part Selection Notice
Part Utilisation Request Participating Employers
Participation Broker-dealers Exchange Offer Passaic River Remediation Natural Resource Damages Claim
Passaic River Remediation Natural Resource Damages Claims Patent Infringement Lawsuit Apotex Inc Corp Involving Plavix
Patent Infringement Lawsuit Apotex Involving Plavix Ongoing Risk Patent Infringement Litigation
Patent Infringement Litigation Against Apotex Related Matters Patent Litigation
Pay Costs Involved Solicitation Proxies Pay Lieu Notice Periods Offsets Executives Employed Outside
Pay Lieu Notice Periods Puerto Rico Executives Expatriate Payment Additional Amounts
Payment Capped Peer Group
Peer Group Analysis Pension Benefits
Pension Other Postretirement Benefit Plans Pension Plan Table
Pension Postretirement Postemployment Liabilities Performance
Performance Awards Performance Goal Award Pool Funding Limits Annual Incentive
Performance Goals Performance Graph
Performance Management System Performance Shares 07-09 Cycle -performance Goals
Performance Shares 07-09 Cycle Goals Performance Shares Agreement
Period 2008 Periodic Review
Permitted Trading Perquisites
Personal Confidential Pfizer
Pharmaceutical Pharmaceutical Growth Drivers
Pharmaceuticals Pharmaceuticals Business Performance
Pharmaceuticals Segment Philadelphia
Photo Identification Required Pipeline
Pipeline Achievements Pipeline Business Developments
Pipeline Developments Plaintiffs Securities Class Action Litigation
Plan Administration Plan Administrator
Plan Assets Plan Description
Plan Funding Plavix
Plavix Australia Plavix Canada Apotex Inc
Plavix Canada Cobalt Plavix Germany
Plavix Korea Plavix Litigation
Plavix Litigation International Plavix Litigation United States
Plavix Litigation-international Plavix Preliminary Injunction Appeal
Policy Against Repricing Stock Options Policy Regarding Stockholder Approval Severance
Possible Lose Market Exclusivity Product Earlier Expected Post Employment Benefit Plan
Post-employment Benefits Post-retirement Medical Life Insurance -employees Service Eligible Benefits
Post-termination Benefits Post-termination Benefits Former Cfo
Potential New Products Powers Obligations Manager
Pravachol Pre-approval Policy Services Provided Independent Registered Public Accounting
Preferred Stock Preplacement Fitness-for-work Evaluation Background Check
Present Value Accumulated Pension Benefits President Health Care Group
President Worldwide Pharmaceuticals Press Releases Conference Calls
Pricewaterhousecoopers Llp Pricing Pressures
Pricing Sales Promotional Practices Litigation Investigations Primary Guarantor Financial Covenants
Prime Vendor Charge-backs Principal Holders Common Stock
Principal Holders Voting Securities Priority Studies
Pro Forma Adjustments Related Assumptions Pro Forma Balance Sheet
Pro Forma Consolidated Statements Earnings Pro Forma Financial Information
Pro Forma Information Sfas 123 Periods Prior 2006 Product
Product Liability Product Liability Litigation
Product Pipeline Developments Product Pipeline Update
Product Sales Productivity Transformation Initiative
Productivity Transformation Update Program Changes 2007
Program Changes 2008 Program Changes 2009
Properties Property Plant Equipment
Property Plant Equipment Net Proposal Approval
Proposed Changes 2007 Provision Documents
Provision Restructuring Net Proxy Solicited Behalf Board Directors Annual Meeting Stockholders
Proxy Statement 2004 Annual Report Available Bristol-myers Squibbs Proxy Statement 2005 Annual Report Available Bristol-myers Squibbs
Proxy Statement 2006 Annual Report Available Bristol-myers Squibbs Prudent Actions Plan Fiduciaries
Puerto Rico Air Emissions Civil Litigation Purpose
Purposes Quantitative Qualitative Disclosures Market Risk
Quarterly Period 2005 Quarterly Period 2006
Quarterly Period 2008 Questions Answers
Ratification Appointment Independent Re-examining Cost Base
Receivables Receivables Net
Receive Admission Ticket Receive Completion Transaction
Receive Information Plan Benefits Receive Paper E-mail Copy Proxy Materials Request Facilitate
Receiving Materials Recent Adverse Changes Global Regional Economic Conditions Continuing
Recently Issued Accounting Standards Recitals
Reclassifications Recognition Actuarial Gains Losses
Reconciliations Gaap Non-gaap Financial Measures Available Website Bmscom Record Date
Recoupment Compensation Redemption Securities
Redemption Tax Event Reduction Time-based Restricted Stock Awards
Registered Pledge Master Security Agreement Registered Public Accounting Firm
Registered Shareholders Registered Stockholders
Registrant8217s Telephone Number Including Area Code 212 546-4000 Registrants Other Certifying Officers Disclosed Based Most Recent
Registrants Telephone Number Including Area Code 212 546-4000 Registrar Paying Agent
Registration 1933 Act Regulation
Related Healthcare Related Party Transactions
Reliance Parties Relies Parties Meet Contractual Regulatory Other Obligations
Relocation Remainder Page Intentionally Left Blank
Repligen Litigation Report Independent Registered Public Accounting Firm
Representation Shares Indivisibility Rights Obligations Partners Representations Warranties
Representations Warranties Purchaser Research Development
Research Development Expenses Continuing Operations Research Development Update
Resolved Responsibilities Duties
Responsibilities Lead Independent Director Rest World
Restatement Previously Issued Financial Statements Restricted Period Means Respect Each Rsu Award Date
Restricted Stock Restricted Stock -upon Signing General Release Employees Eligible
Restricted Stock Awards Units Restricted Stock Units
Restriction Repricing Loans Restructuring
Result Sum Segment Sales International Domestic Not Tie Result Sum Segment Sales Not Tie Total
Results Results Operations
Results Operations Financial Condition Retirement Benefits
Retirement Death Retirement Income Plan
Retirement Plan Retirement Program
Revenue Recognition Reverse
Reviewed Annual Report Form 10-k Bristol-myers Squibb Revoke Proxy
Reyataz Right Severance Payments Benefits
Rights Privileges Erisa Risk Factors
Role Management Rollforward
Royal Bank Scotland Royal Bank Scotland Plc
Rule Puerto Rico Expatriate Executives Above Only Rules Territory Management Committee
Rxusa Wholesale Litigation Safety Problem Well Reference 141 Bylaws Meaning Presented
Sale Canadian Consumer Medicines Business Sales Rebate Return Accruals
Sales Returns Sanofi
Sanofi Pharma Bristol-myers Squibb Sanofi-aventis
Sanpaolo Imi Spa Sarbanes-oxley Act 2002
Satisfaction Discharge Savings Plan
Savings Plans Savings Plans -employees Eligible Benefits Accumulated Investment Program
Schedule Schedule 508
Schedules Scheme Defraud
Science Technology Committee Seal
Sec Consent Order Sec Consent Order Deferred Prosecution Agreement
Sec Germany Investigation Sec Investigation Wholesaler Inventory Accounting Matters
Sec Reporting Securities Exchange Act 1934
Securities Exchange Act 1934 Amendment Securities Litigation
Securities Litigation Investigations Securities Registered Pursuant Act
Security Forms Security Ownership Certain Beneficial Owners Management Related Stockholder
Segment Information Segment Results
Select Additional Financial Information Select Balance Sheet Information
Selected Balance Sheet Cash Update Selected Balance Sheet Cash Updates
Selected Balance Sheet Information Senior Executive Performance Incentive Plan
Senior Executive Severance Plan Senior Notes Due 2016
Senior Notes Due 2021 Serzone
Settlement Shareholder Class Action Litigation Several Key Management Changes Announced
Severance Payments Benefits Severance Plan
Severance Protection Shall Automatically Forfeit Rights Respect Rsus Date Such
Share Ownership Retention Guidelines Share Retention Requirements
Shareholder Derivative Actions Shareholder Derivative Lawsuit
Shareholder Derivative Lawsuits Shares Committed Equity Compensation
Shipping Handling Costs Short-term Borrowings Long-term Debt
Signature Page Follows Signatures
Similar Proposal Voted Computer Associates Sinking Funds
Sole Risk Scenario Sources Availability Raw Materials
Special Regarding Forward-looking Statements Specified
Specified Employees Specified Including Impairment Charge
Specify Shares Voted Spending
Starkman Litigation State Other Jurisdiction Incorporation
Statement Bristol-myers Squibb Board Directors Statement Cautionary Factors
Statement Intent Statement Kenneth Steiner
Statement Mead Johnson Nutrition Registration Statement Nick Rossi
Status Previously Disclosed Internal Control Stock Award Incentive Plan
Stock Compensation Stock Compensation Plans
Stock Option Valuation Stock Options
Stock-based Compensation Expense Stock-based Program
Stockholder Action Stockholder Nominations Director
Stockholder Proposal Animal Testing Stockholder Proposal Animal Treatment
Stockholder Proposal Cumulative Voting Stockholder Proposal Executive Compensation Disclosure
Stockholder Proposal Hiv Aids-tb-malaria Stockholder Proposal Political Contributions
Stockholder Proposal Recoupment Stockholder Proposal Restatement Situations
Stockholder Proposal Restricted Stock Stockholder Proposal Separation Chairman Ceo Positions
Stockholder Proposal Simple Majority Vote Stockholder Proposal Special Shareowner Meetings
Stockholder Proposals Stockholders
Strategic Alliances Arrangements Strategic Plan Performance Share Award Goals
Strategic Review Strategic Update
Strategy Strong Operational Strategic Performance Caps Transformative 2009
Sub-license Subject Certain Conditions
Submission Matters Vote Security Holders Submissions
Subsequent Event Subsequent Events
Successors Assigns Summary
Summary 2005 Board Directors Compensation Program Summary Compensation Table
Summary Financial Information Summary Plan Description
Supplemental General Release Supplemental Indenture
Supplemental Severance Supply Active Substance Chemical Bulk
Supporting Statement Table Contents
Tax Accounting Implications Executive Compensation Program Tax Benefit Qualified Production Activities
Tax Contingencies Tax Implications Executive Compensation Program
Tax Preparation Services Taxes
Telephone 212 546-4000 Tequin Injectable Form
Term Term Amendment Performance Plan
Term Termination Terminated Swap Contracts
Termination Termination Dolan
Termination Indemnity Plans Termination Price
Terms Co-promotion Agreement Territory
Territory Management Committee Timetables
Timing Equity Awards Trademarks Patents Infringement
Trademarks Used Territory Train
Transfers Shares Transition Payment
Trustees Certificate Authentication Ubs London Branch
Undistributed Earnings Foreign Subsidiaries Unfunded Obligation
United Kingdom United States
Unmet Medical Need Unregistered Sales Equity Securities Proceeds
Update Investment Community Update Strategic Review Non-pharmaceutical Businesses
Vacation Valet Parking Hotel Dupont Available Own Expense
Validity Severability Valuation Qualifying Accounts
Vanlev Litigation Virology
Voluntary Termination Vote Beneficial Stockholder
Vote Confidential Vote Important
Vote Registered Stockholder Votes Counted
Votes Needed Proposals Pass Voting Securities Principal Holders
Wachovia Bank National Association Wage Litigation
Weisz Stephenson Litigations What Board Directors Voting Recommendations
What Householding Work What Notice Access Affect
What Voted Annual Meeting Wholesaler Distribution Channel
Wholesaler Sales Channel Stuffing Wic Rebates
William Street Credit Corporation Withholding Taxes
Witnesseth Working Capital
Year-end Option Sar Values Year-to-date
Yeda Litigation Zymogenetics
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki